Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TMO Renewables was a British industrial biotechnology company focused on the development of second-generation biofuels. The company utilized a proprietary process involving thermophilic microorganisms, specifically a modified strain of Geobacillus, to convert lignocellulosic biomass into bioethanol. This technology was designed to process a wide range of feedstocks, including agricultural residues and municipal solid waste, into high-value renewable fuel. TMO operated a process development unit in Guildford and secured significant international partnerships, notably in China and Brazil. The company's approach aimed to provide a sustainable alternative to first-generation biofuels by utilizing non-food sources. However, the company faced financial difficulties and entered administration in 2013.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TMO Renewables.